首页> 外文期刊>Journal of cardiovascular electrophysiology >Long term performance and safety of His bundle pacing: A multicenter experience
【24h】

Long term performance and safety of His bundle pacing: A multicenter experience

机译:他捆绑起搏的长期性能和安全:多中心经验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Introduction Several single-center short-term studies have demonstrated the feasibility, safety, and positive clinical outcomes of permanent His bundle pacing (HBP). We performed a retrospective study to evaluate long-term technical and safety performances of HBP in a large population of pacemaker patients from two different centers. Methods and Results The analysis includes 844 patients (345 female, mean age = 75 +/- 9 years) who underwent successful permanent HBP for pacemaker indications from 2004 to 2016. The main endpoints were long term electrical performances including pacing threshold, sensing, impedance, and freedom from pacing related complications. The pacing indication was AV Block in 348 (41.2%) patients, sinus node disease in 147 (17.4%), any bradycardia indication in patients with atrial fibrillation in 335 (39.7%) patients and need for cardiac resynchronization therapy in 14 (1.7%) patients. Mean pacing capture thresholds and sensed R waves were 1.6 V and 5.8 mV, respectively at implant and 2.0 V and 6.1 mV at chronic follow-up. During the median follow up of 3 years (interquartile range = 1-6 years), HBP was free of any complication in 91.6% of patients. In the first 368 patients, HBP was achieved using a deflectable curve delivery system, while in 476 using the fixed curve sheath. A significant difference was found in the thresholds (2.4 +/- 1.0 V and 1.7 +/- 1.1 V, P < .001, respectively) and complications (11.9% and 4.2%, P < .001, respectively) between the two groups. Conclusions Permanent HBP was safe and effective during long-term follow-up. The fixed curved delivery sheath offered significantly better electrical parameters and reliability over time. The results of this multicenter study are consistent with recent studies.
机译:简介几项单中心短期研究表明,永久的束起搏(HBP)的可行性,安全性和阳性临床结果。我们进行了回顾性研究,以评估来自两种不同中心的大量起搏器患者中HBP的长期技术和安全性能。方法和结果分析包括844名患者(345名女性,平均年龄= 75 +/- 9岁),他们从2004年到2016年开始成功的起搏器指示的成功永久性HBP。主要终点是长期电气表演,包括起搏阈值,传感,阻抗以及免于起搏相关并发症的自由。 PACIPING指示是348(41.2%)患者的AV嵌段,鼻窦疾病147(17.4%),335例(39.7%)患者的心房颤动患者的任何心动过缓指示,需要14例心脏重新同步治疗(1.7% ) 耐心。平均起搏捕获阈值和感测的R波分别为1.6V和5.8mV,分别在植入物和2.0V和6.1mV下进行慢性随访。在3年(四分位数= 1-6岁)的中位后,HBP在91.6%的患者中没有任何并发​​症。在前368名患者中,使用可偏转的曲线输送系统实现HBP,而在476中使用固定曲线护套。在两组之间的阈值(2.4 +/- 1.0V和1.7 +/- 1.1V,p <.001,分别为11.9%和4.2%,p <.001)之间存在显着差异。两组之间的并发症(分别为11.9%和4.2%) 。结论在长期随访期间,永久性HBP是安全有效的。固定弯曲递送护套提供了显着更好的电气参数和随时间可靠性。该多中心研究的结果与最近的研究一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号